Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| HDFC Pharma and Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | HDFC | Edelweiss |
| NAV | ₹23.6750 | ₹36.4592 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 3.1 years | 8.7 years |
| Expense ratio | 1.1% | 1.4% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 94.50 | 45.20 |
Returns
| HDFC Pharma and Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| 1 month | +12.97% | +5.92% |
| 3 months | +7.13% | +2.40% |
| 6 months | +17.84% | +20.35% |
| YTD | +33.73% | +25.20% |
| 1 year | +32.20% | +23.75% |
| 3 years (CAGR) | +30.70% | +17.13% |
| 5 years (CAGR) | — | +11.04% |
| 10 years (CAGR) | — | — |
| Since launch | +31.83% | +15.95% |
Risk
| HDFC Pharma and Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| Volatility | 15.8% | 20.9% |
| Downside volatility | 8.5% | 12.9% |
| Sharpe | 1.53 | 0.51 |
| Sortino | 2.86 | 0.82 |
| Calmar | 2.06 | 0.69 |
| Return / risk | 1.95 | 0.82 |
| Deepest fall | −14.91% | −32.34% |
| Days to recover | 126 | 155 |
| Below its high | +0.00% | −1.63% |
Against benchmark
| HDFC Pharma and Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| Alpha | +7.54% | +5.69% |
| Beta | 0.97 | 0.97 |
| R² | 85.0% | 56.3% |
| Up capture | 108.9% | 114.2% |
| Down capture | 71.0% | 93.5% |
| Tracking error | 6.1% | 13.8% |
| Information ratio | 1.17 | 0.40 |
| Treynor | 0.24 | 0.10 |
Consistency
| HDFC Pharma and Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| Best 1-year | +67.01% | +98.01% |
| Middle 1-year | +23.25% | +17.30% |
| Worst 1-year | +1.71% | −23.25% |
| 1-year periods with a loss | 0.0% | 23.7% |
| Middle 3-year | +30.22% | +18.97% |
| Positive months | 72.2% | 66.7% |
| Best day | +3.18% | +3.68% |
| Worst day | −3.61% | −5.79% |
| Worst 5% day | −1.51% | −1.93% |
| Positive days | 58.3% | 57.6% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| HDFC Pharma and Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| 5-year XIRR | — | +17.87% |
| 5-year value | — | ₹9,45,521 |
| 3-year XIRR | +27.71% | +18.35% |
| 1-year XIRR | +41.37% | +35.31% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.